Predicted to enable low-density lipoprotein particle receptor binding activity; phosphatidylinositol binding activity; and protein C-terminus binding activity. Acts upstream of or within circulatory system development; kidney development; and receptor-mediated endocytosis. Located in endosome. Orthologous to human SNX17 (sorting nexin 17). [provided by Alliance of Genome Resources, Apr 2022]